Related Experiment Videos
[Differentiating between tumor and implant material in the postoperative sella using MRT]
W A Kaiser1, V Steckelbroeck, B Siewert
1Radiologische Universitätsklinik, Bonn.
Summary
Magnetic resonance imaging (MRT) criteria help differentiate pituitary tumor remnants from implant material after surgery. This imaging technique aids in evaluating surgical success and diagnosing residual or recurrent tumors.
Area of Science:
- Neurosurgery
- Radiology
- Endocrinology
Background:
- Transsphenoidal hypophysectomy is a common surgical procedure for pituitary tumors.
- Distinguishing between residual tumor and surgical implant material post-operatively can be challenging.
- Accurate postoperative assessment is crucial for patient management and treatment planning.
Purpose of the Study:
- To develop and validate magnetic resonance imaging (MRT) criteria for differentiating pituitary tumor remnants from implant material.
- To assess the diagnostic performance of MRT in identifying residual or recurrent pituitary tumors.
- To provide guidance for the use of MRT in postoperative evaluation of hypophyseal tumors.
Main Methods:
- Retrospective analysis of MRT scans from 50 patients who underwent transsphenoidal hypophysectomy.
- Utilized T1-weighted spin-echo sequences with Gd-DTPA contrast enhancement.
- Correlated MRT findings with postoperative hormonal status and operative notes.
Main Results:
- Implant material typically appeared as sandwich-like, linear, or circular structures.
- Residual/recurrent tumor showed homogenous or non-homogenous patterns without marginal enhancement in 84% of cases.
- Infundibular displacement was observed in 73% of patients with tumor remnants.
- MRT demonstrated a sensitivity of 70%, specificity of 95%, positive predictive value of 94%, and negative predictive value of 72%.
Conclusions:
- Established MRT criteria effectively differentiate tumor remnants from implant material after hypophysectomy.
- MRT is a valuable tool for assessing surgical success and diagnosing residual or recurrent pituitary tumors.
- Recommended for routine use in postoperative evaluation of hypophyseal tumors when clinical doubt exists.